BrainChip Stock Climbs 50% from February Low, but €0.14 Resistance and Cash Burn Loom

BrainChip’s shares have staged a sharp reversal since touching their February floor, climbing roughly 50% to trade at €0.12. The recovery has gathered momentum on the back of both technical tailwinds and a flurry of strategic announcements, placing the stock at a critical juncture where chart levels and operational execution intersect.

The company deepened its Asian footprint last week by signing a partnership with MicroIP, a Taiwanese specialist in system design and software integration. The collaboration targets ultra-low-power AI applications spanning speech processing, radar analytics and cybersecurity. MicroIP had previously hinted at the tie-up during the COMPUTEX trade fair, and the deal now adds a concrete layer to BrainChip’s channel strategy. No revenue figures have been disclosed from the agreement, but it reinforces the firm’s push to embed its neuromorphic technology in global electronics.

AKD1500 production timeline solidifies

Alongside the partnership, BrainChip provided fresh clarity on its processor roadmap. Volume production of the AKD1500 chip is scheduled to commence in summer 2026, with an initial batch of around 70,000 units. The processors are aimed at defence, robotics and industrial customers. To make the hardware production-ready, the company has onboarded three new software partners tasked with building a machine-learning library. Development of the follow-on AKD2500 is already underway, and additional strategic licensing agreements have been signed, including one with a subsidiary of Lockheed Martin.

Financially, however, the picture remains strained. First-quarter customer inflows reached only $664,000, while operating expenses clocked in at nearly $5.3 million. Research and development alone consumed over $2.7 million. The MicroIP deal has yet to generate any announced revenue, leaving a yawning gap between cash burn and top-line traction.

Should investors sell immediately? Or is it worth buying BrainChip?

Technical structure supports — for now

On the charts, the €0.12 level sits comfortably above all three major moving averages. The 50-day line at €0.10 lies roughly 19% below the current price, and the 200-day average coincides at the same level. A simultaneous crossover of the three averages is typically read as a constructive signal, creating a support base beneath the stock.

The 14-day relative strength index registers at 64, approaching but not yet inside overbought territory. A 7-day gain of roughly 9% has lifted the RSI, and the proximity to the 70 mark deserves attention — momentum sellers tend to become more active there. The key technical question over the coming sessions is whether the rally can sustain itself without triggering profit-taking.

The most formidable resistance sits at €0.14, the 52-week high from October 2025. The stock still needs to gain about 16% to test that zone. Investors who bought near that peak are currently sitting on an annualised loss of roughly 12%, creating a natural overhang of supply as the price approaches. A sustained breakout above €0.14 would fundamentally shift the chart narrative from recovery to a genuine uptrend; until then, the move remains corrective.

Zone trading amid 74% volatility

With annualised 30-day volatility running at 74%, support and resistance levels should be treated as zones rather than precise trigger points. The 50-day moving average at €0.10 serves as the key line in the sand: as long as the stock holds above it, the medium-term upward bias remains intact. A close below would materially weaken the current thesis.

BrainChip at a turning point? This analysis reveals what investors need to know now.

External catalysts also loom. US inflation data due on June 10 and 11 will directly shape interest-rate expectations, a critical factor for speculative technology names. A softer print would reinforce the rally, while a hot number could compress valuation multiples. The subsequent Federal Reserve meeting adds another layer of uncertainty.

In the months ahead, hard data becomes paramount. The company must deliver verifiable licensing revenue and concrete production orders to justify its valuation and stem the cash burn. For now, the market is rewarding narrative as much as numbers — but the gap between the two is narrowing. The €0.14 barrier and the summer production ramp will determine whether this rally has legs or is merely a technical reflex.

Ad

BrainChip Stock: New Analysis - 9 June

Fresh BrainChip information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BrainChip analysis...

en | AU000000BRN8 | BRAINCHIP | boerse | 69508936 |